The Discounted Cash Flow (DCF) valuation of Middle East Healthcare Company PJSC (4009.SR) is 37.56 SAR. With the latest stock price at 59.95 SAR, the upside of Middle East Healthcare Company PJSC based on DCF is -37.4%.
Based on the latest price of 59.95 SAR and our DCF valuation, Middle East Healthcare Company PJSC (4009.SR) is a sell. selling 4009.SR stocks now will result in a potential gain of 37.4%.
| Range | Selected | |
| WACC / Discount Rate | 10.4% - 12.5% | 11.5% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 26.52 - 55.57 | 37.56 |
| Upside | -55.8% - -7.3% | -37.4% |